Pipeline & Patients

BioNTech AG develops and commercializes a broad product pipeline using different scientific approaches and cutting-edge technology platforms. BioNTech´s clinical pipeline represents a number of industry firsts.

BioNTech is the first company worldwide to:

… build and implement a medical genomics-driven design and GMP-approved manufacturing process for individual patient-specific therapies

… enter the clinic to test an mRNA-based individualized cancer vaccine targeting neoantigens

… enter the clinic with an mRNA-based individualized vaccine drawn from a warehouse of mRNAs encoding cancer-selective antigens

… test an intravenous formulation of a mRNA vaccine in clinical trials